ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Delay in diagnosis significantly impact lives of patients with Fibromyalgia, new survey reports
Friday 3 December 2010
DELAY IN DIAGNOSIS SIGNIFICANTLY IMPACTS LIVES OF PATIENTS WITH FIBROMYALGIA, NEW SURVEY REPORTS
National findings reveal greater awareness, earlier diagnosis, and support help reduce daily life challenges
RED BANK, N.J., November 22, 2010 /PRNewswire/ — Results released today from a national survey of U.S. women with fibromyalgia, illustrate the private and prolonged physical and emotional struggles patients with this condition face, underscored by delays in diagnosis, which a majority of respondents report as being one year or longer. As a result of fibromyalgia, two thirds (67%) of respondents say they are unable to keep up with household chores, nearly half (47%) report that their work life or career has been negatively affected, and two in five (42%) spend less quality time with their friends. Nearly one third (31%) say fibromyalgia has negatively affected their ability to experience intimacy.
Fibromyalgia is a condition marked by chronic, widespread pain and tenderness, and decreased physical function. It affects six to 12 million Americans, mostly women, three-quarters of whom are estimated to be undiagnosed. Results of the 48-state, 508-person survey were released by HealthyWomen.org, the nation’s leading independent source of health information for women. The survey was sponsored by Forest Laboratories, Inc.
“Fibromyalgia is a common medical condition affecting women,” said Elizabeth Battaglino Cahill, Executive Director of HealthyWomen.org and a registered nurse. “It is estimated that there could be as many American women living with fibromyalgia as there are living with diabetes. And while increased awareness has dramatically improved care for patients with this condition, we still have a lot of work to do to ensure patients have the support they need to live their lives fully.”
Remarkably, one in four (23%) respondents report having suffered for at least five years before receiving a diagnosis for their condition. Most respondents (71%) say they waited until they could no longer tolerate their symptoms before seeking a diagnosis. Examples of perceived barriers to a proper diagnosis include patients’ own lack of knowledge about the condition and physicians not recognizing symptoms.
Although fibromyalgia is a chronic disorder, a majority of respondents say they fear skepticism about their condition, with 64% expressing concern about being taken seriously, and 79% indicating the top quality they seek in a healthcare professional is assurance that their condition is being taken seriously.
“This survey quantifies what patients and their supporters have known and experienced – that stigma, skepticism, lack of knowledge about fibromyalgia, and delays in diagnosis contribute negatively to patient outcomes,” added Battaglino Cahill. “However, with more knowledge, patients are overcoming these barriers to improving their lives, and that is an important lesson we can take away from this survey.”
Early diagnosis is important
Respondents whose diagnosis was delayed were more likely to report severe symptoms (68%) at the time of diagnosis, compared to those who were diagnosed within a year (42%). Patients diagnosed within a year are also significantly less likely to experience daily challenges in management of their households, relationships and careers.
“An earlier diagnosis is important,” said David Edelberg, M.D., founder of WholeHealth Chicago and a physician specializing in fibromyalgia treatment. “The sooner patients are diagnosed, the sooner they can begin an effective management plan and get back to their daily activities. This is why it’s critical for both doctors and patients to communicate effectively and for patients to not wait until they can no longer bear their symptoms before seeking help.”
Effective treatment and support from loved ones are critical
Since being treated, 51% of patients believe that their overall day-to-day life has improved. In addition, a greater number of patients who received more support from their spouse report that their day-to-day life has improved due to treatment (56%), compared to those who received the same amount of or less support (47%) since being treated.
Respondents say the following types of treatment have improved their symptoms:
Unfortunately, many patients do not receive the support from friends and loved ones that they need:
“Arriving at an earlier and accurate diagnosis is only the first step for patients with fibromyalgia,” said Battaglino Cahill. “Women need to work closely with their physicians to find an effective treatment plan, and friends and loved ones must do their part to provide the ongoing encouragement that is critical to a patient’s improvement.”
About the survey
The survey, known as WE FEEL (Women Expressing Fibromyalgia’s Effects on their Everyday Lives), was designed to gather data and better understand perspectives on diagnosis and treatment, the relationship between fibromyalgia patients and their physicians, the impact of the condition on patients’ daily activities, and the types of support patients need and receive.
Research for WE FEEL was conducted by Edelman StrategyOne, using the field services of Harris Interactive Service Bureau. The 20-minute survey was fielded between May 5 and May 11, 2010. The findings are nationally representative of diagnosed, female fibromyalgia sufferers in the US. The total sample of 508 yields a margin of error of ±4.4% at the 95% confidence level, which means that 95 out of 100 times that a sample of this size is drawn, the results will not vary by more than 4.4 percentage points in either direction. The statistical significance is reported at the 95% level.
HealthyWomen (HW) is the nation’s leading independent health information source for women. For more than 20 years, women have been turning to HW for answers to their most pressing and personal health care questions. HW provides health information through a wide array of online content and print publications that are original, objective and reviewed and approved by medical experts. Its website, www.HealthyWomen.org®, was recognized by ForbesWoman as one of the “Top 100 Websites for Women” and was named the top women’s health website by Dr. Mehmet Oz in O, The Oprah Magazine and by Good Housekeeping magazine. To learn more, visit www.HealthyWomen.org.
About Forest Laboratories, Inc.
Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people’s lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest’s current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York. To learn more about Forest Laboratories, visit http://www.FRX.com.
The above originally appeared here.
blog comments powered by Disqus